Yifan Pharmaceutical Co., Ltd.

¥9.60As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002019Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.32%)
Div yield 1.04%
ROE 3.13%
Drug Manufacturers (General)
Beta (5Y) 0.47
PE TTM 37.58
TSR TTM (26.40%)
Mkt cap ¥9.904B
ROIC 3.00%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥12
25.23%
(80.68%)
Hold 9|9|8|1|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.13
0.13
0.14
0.15
19.19%
15.52%
15.50%
8.21%
Revenue¥M
951.0
990.5
980.6
954.7
7.27%
7.77%
5.37%
5.13%
Peers (US$1.485B)
Cap (US$)
PE
1.545B
—
1.479B
—
Capital
TTM
5Y
10Y
Leveragex
0.861
0.907
0.808
EBIT/Intx
1.409
0.144
0.134
Own earn%
(74.31)
13.81
6.93
Sh yield%
6.00
25.44
32.85
Owners
Insiders/Inst%
11.01
54.50
Short interest%
2.76
SBC / revenue%
1.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
8–13
$1 testx
0.2
Incr. ROIC%
3